Literature DB >> 20680517

Sedation confounds outcome prediction in cardiac arrest survivors treated with hypothermia.

Edgar A Samaniego1, Michael Mlynash, Anna Finley Caulfield, Irina Eyngorn, Christine A C Wijman.   

Abstract

BACKGROUND: Therapeutic hypothermia is commonly used in comatose survivors' post-cardiopulmonary resuscitation (CPR). It is unknown whether outcome predictors perform accurately after hypothermia treatment.
METHODS: Post-CPR comatose survivors were prospectively enrolled. Six outcome predictors [pupillary and corneal reflexes, motor response to pain, and somatosensory-evoked potentials (SSEP) >72 h; status myoclonus, and serum neuron-specific enolase (NSE) levels <72 h] were systematically recorded. Poor outcome was defined as death or vegetative state at 3 months. Patients were considered "sedated" if they received any sedative drugs ≤ 12 h prior the 72 h neurological assessment.
RESULTS: Of 85 prospectively enrolled patients, 53 (62%) underwent hypothermia. Furthermore, 53 of the 85 patients (62%) had a poor outcome. Baseline characteristics did not differ between the hypothermia and normothermia groups. Sedative drugs at 72 h were used in 62 (73%) patients overall, and more frequently in hypothermia than in normothermia patients: 83 versus 60% (P = 0.02). Status myoclonus <72 h, absent cortical responses by SSEPs >72 h, and absent pupillary reflexes >72 h predicted poor outcome with a 100% specificity both in hypothermia and normothermia patients. In contrast, absent corneal reflexes >72 h, motor response extensor or absent >72 h, and peak NSE >33 ng/ml <72 h predicted poor outcome with 100% specificity only in non-sedated patients, irrespective of prior treatment with hypothermia.
CONCLUSIONS: Sedative medications are commonly used in proximity of the 72-h neurological examination in comatose CPR survivors and are an important prognostication confounder. Patients treated with hypothermia are more likely to receive sedation than those who are not treated with hypothermia.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 20680517      PMCID: PMC3153345          DOI: 10.1007/s12028-010-9412-8

Source DB:  PubMed          Journal:  Neurocrit Care        ISSN: 1541-6933            Impact factor:   3.210


  25 in total

Review 1.  Use of in vitro and in vivo data to estimate the likelihood of metabolic pharmacokinetic interactions.

Authors:  R J Bertz; G R Granneman
Journal:  Clin Pharmacokinet       Date:  1997-03       Impact factor: 6.447

2.  Predictive power of serum NSE and OHCA score regarding 6-month neurologic outcome after out-of-hospital ventricular fibrillation and therapeutic hypothermia.

Authors:  Tuomas Oksanen; Marjaana Tiainen; Markus B Skrifvars; Tero Varpula; Anne Kuitunen; Maaret Castrén; Ville Pettilä
Journal:  Resuscitation       Date:  2008-10-26       Impact factor: 5.262

Review 3.  Is this patient dead, vegetative, or severely neurologically impaired? Assessing outcome for comatose survivors of cardiac arrest.

Authors:  Christopher M Booth; Robert H Boone; George Tomlinson; Allan S Detsky
Journal:  JAMA       Date:  2004-02-18       Impact factor: 56.272

4.  Somatosensory evoked potentials during mild hypothermia after cardiopulmonary resuscitation.

Authors:  A Bouwes; J M Binnekade; D F Zandstra; J H T M Koelman; I N van Schaik; A Hijdra; J Horn
Journal:  Neurology       Date:  2009-11-03       Impact factor: 9.910

5.  Cardiopulmonary resuscitation of adults in the hospital: a report of 14720 cardiac arrests from the National Registry of Cardiopulmonary Resuscitation.

Authors:  Mary Ann Peberdy; William Kaye; Joseph P Ornato; Gregory L Larkin; Vinay Nadkarni; Mary Elizabeth Mancini; Robert A Berg; Graham Nichol; Tanya Lane-Trultt
Journal:  Resuscitation       Date:  2003-09       Impact factor: 5.262

6.  Prognostic value of brain diffusion-weighted imaging after cardiac arrest.

Authors:  Christine A C Wijman; Michael Mlynash; Anna Finley Caulfield; Amie W Hsia; Irina Eyngorn; Roland Bammer; Nancy Fischbein; Gregory W Albers; Michael Moseley
Journal:  Ann Neurol       Date:  2009-04       Impact factor: 10.422

7.  Serum neuron-specific enolase and S-100B protein in cardiac arrest patients treated with hypothermia.

Authors:  Marjaana Tiainen; Risto O Roine; Ville Pettilä; Olli Takkunen
Journal:  Stroke       Date:  2003-11-20       Impact factor: 7.914

8.  A prospective study of nontraumatic coma: methods and results in 310 patients.

Authors:  D Bates; J J Caronna; N E Cartlidge; R P Knill-Jones; D E Levy; D A Shaw; F Plum
Journal:  Ann Neurol       Date:  1977-09       Impact factor: 10.422

9.  Neuron specific enolase and S-100B as predictors of outcome after cardiac arrest and induced hypothermia.

Authors:  Malin Rundgren; Torbjörn Karlsson; Niklas Nielsen; Tobias Cronberg; Per Johnsson; Hans Friberg
Journal:  Resuscitation       Date:  2009-05-20       Impact factor: 5.262

10.  Biphasic concentration change during continuous midazolam administration in brain-injured patients undergoing therapeutic moderate hypothermia.

Authors:  Noriyasu Fukuoka; Mayuki Aibiki; Toyohisa Tsukamoto; Keisuke Seki; Shushi Morita
Journal:  Resuscitation       Date:  2004-02       Impact factor: 5.262

View more
  84 in total

Review 1.  Cardiopulmonary resuscitation and management of cardiac arrest.

Authors:  Jerry P Nolan; Jasmeet Soar; Volker Wenzel; Peter Paal
Journal:  Nat Rev Cardiol       Date:  2012-06-05       Impact factor: 32.419

2.  Prognosis after cardiac arrest and hypothermia: a new paradigm.

Authors:  Edgar A Samaniego; Suzanne Persoon; Christine A C Wijman
Journal:  Curr Neurol Neurosci Rep       Date:  2011-02       Impact factor: 5.081

Review 3.  [Prognostic assessment as the basis for limiting therapy in unconscious patients after cardiopulmonary resuscitation].

Authors:  H-R Arntz; H-C Mochmann
Journal:  Med Klin Intensivmed Notfmed       Date:  2014-11-05       Impact factor: 0.840

4.  Therapeutic hypothermia and reliability of somatosensory evoked potentials in predicting outcome after cardiopulmonary arrest.

Authors:  Ted Laurence Rothstein
Journal:  Neurocrit Care       Date:  2012-08       Impact factor: 3.210

5.  The Prognostic Value of 48-h Continuous EEG During Therapeutic Hypothermia After Cardiac Arrest.

Authors:  Marta Lamartine Monteiro; Fabio Silvio Taccone; Chantal Depondt; Irene Lamanna; Nicolas Gaspard; Noémie Ligot; Nicolas Mavroudakis; Gilles Naeije; Jean-Louis Vincent; Benjamin Legros
Journal:  Neurocrit Care       Date:  2016-04       Impact factor: 3.210

Review 6.  The Influence of Therapeutics on Prognostication After Cardiac Arrest.

Authors:  Sachin Agarwal; Nicholas Morris; Caroline Der-Nigoghossian; Teresa May; Daniel Brodie
Journal:  Curr Treat Options Neurol       Date:  2019-11-25       Impact factor: 3.598

7.  In reply.

Authors:  Frank Thömke
Journal:  Dtsch Arztebl Int       Date:  2013-06       Impact factor: 5.594

8.  Neurological examination of critically ill patients: a pragmatic approach. Report of an ESICM expert panel.

Authors:  Tarek Sharshar; Giuseppe Citerio; Peter J D Andrews; Arturo Chieregato; Nicola Latronico; David K Menon; Louis Puybasset; Claudio Sandroni; Robert D Stevens
Journal:  Intensive Care Med       Date:  2014-02-13       Impact factor: 17.440

9.  The neuron specific enolase (NSE) ratio offers benefits over absolute value thresholds in post-cardiac arrest coma prognosis.

Authors:  Hangyul M Chung-Esaki; Gracia Mui; Michael Mlynash; Irina Eyngorn; Kyle Catabay; Karen G Hirsch
Journal:  J Clin Neurosci       Date:  2018-08-23       Impact factor: 1.961

Review 10.  Assessing prognosis following cardiopulmonary resuscitation and therapeutic hypothermia-a critical discussion of recent studies.

Authors:  Frank Thömke
Journal:  Dtsch Arztebl Int       Date:  2013-03-01       Impact factor: 5.594

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.